INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (INO)

CUSIP: 45773H409

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
66,777,963
Total 13F shares
33,075,457
Share change
+12,371,821
Total reported value
$57,545,189
Put/Call ratio
13%
Price per share
$1.74
Number of holders
98
Value change
+$21,224,322
Number of buys
43
Number of sells
39

Quarterly Holders Quick Answers

What is CUSIP 45773H409?
CUSIP 45773H409 identifies INO - INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (INO) as of Q4 2025

As of 31 Dec 2025, INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (INO) was held by 98 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 33,075,457 shares. The largest 10 holders included FMR LLC, VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Boxer Capital Management, LLC, D. E. Shaw & Co., Inc., ADAR1 Capital Management, LLC, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, and BlackRock, Inc.. This page lists 98 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.